Literature DB >> 30481516

Endovascular Versus Open Repair for Chronic Type B Dissection Treatment: A Meta-Analysis.

Mourad Boufi1, Benjamin O Patterson2, Anderson D Loundou3, Laurent Boyer3, Matthew J Grima2, Ian M Loftus2, Peter J Holt2.   

Abstract

BACKGROUND: The respective place of endovascular repair (ER) versus open surgery (OS) in thoracic dissecting aneurysm treatment remains debatable. This comprehensive review seeks to compare the outcomes of ER versus OS in chronic type B aortic dissection treatment.
METHODS: Embase and Medline searches (2000 to 2017) were performed following PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses) guidelines. Outcomes data extracted comprised (1) early mortality and major complications: stroke, spinal cord ischemia (SCI), dialysis, and respiratory complications; and (2) late survival and reinterventions. Reintervention causes were divided into proximal, adjacent, and distal. Comparative studies allowed comparative meta-analysis. Noncomparative studies were analyzed in pooled proportion meta-analyses for each group.
RESULTS: A total of 39 studies were identified after exclusions, of which 4 were comparative. Comparative meta-analysis demonstrated lower early mortality for ER (odds ratio [OR], 4.13; 95% confidence interval [CI], 1.10 to 15.4), stroke (OR, 4.33; 95% CI, 1.02 to 18.35), SCI (OR, 3.3; 95% CI, 0.97 to 11.25), and respiratory complications (OR, 6.88; 95% CI,1.52 to 31.02), but higher reintervention rate (OR, 0.34; 95% CI, 0.16 to 0.69). Midterm survival was similar (OR, 1.19; 95% CI, 0.42 to 3.32). Noncomparative studies demonstrated that most reinterventions were related to the aortic segment distal to primary intervention in both groups (OS 73%, ER 59%). Reintervention procedures were mainly surgical for OS (85%), mainly endovascular for ER (75%). Rupture rates were 1.2% (OS) and 3% (ER).
CONCLUSIONS: Endovascular repair is associated with significant early benefits, but this is not sustained at midterm. Reintervention is more frequent, but the OS is not exempt from reintervention or late rupture. Both techniques have their place, but patient selection is key.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30481516     DOI: 10.1016/j.athoracsur.2018.10.045

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Laser fenestration in chronic type B aortic dissection: creating a distal landing zone to facilitate thoracic endovascular aortic repair.

Authors:  Stevan S Pupovac; Jonathan M Hemli; Alfio Carroccio; Khalil Qato; Elizabeth Northfield; Derek R Brinster
Journal:  Ann Cardiothorac Surg       Date:  2022-01

2.  Thoracic endovascular repair of chronic type B aortic dissection: a systematic review.

Authors:  Michael L Williams; Madeleine de Boer; Bridget Hwang; Bruce Wilson; John Brookes; Nicholas McNamara; David H Tian; Timothy Shiraev; Ourania Preventza
Journal:  Ann Cardiothorac Surg       Date:  2022-01

3.  All type B aortic dissections should undergo thoracic endovascular aneurysm repair.

Authors:  Saket Singh; Naiem Nassiri; Prashanth Vallabhajosyula
Journal:  JTCVS Tech       Date:  2021-08-09

4.  Early outcomes of the Frozenix J-graft with exclusion of the non-stent part at a single center.

Authors:  Akimasa Morisaki; Yosuke Takahashi; Hiromichi Fujii; Yoshito Sakon; Kenta Nishiya; Noriaki Kishimoto; Kokoro Yamane; Takumi Kawase; Toshihiko Shibata
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

5.  Descending thoracic aortic repair outcomes for chronic aortic dissection: a single-centre experience.

Authors:  Yoshitaka Yamane; Susumu Oshima; Kazumasa Ishiko; Makoto Okiyama; Tomohiro Hirokami; Yuki Hirai; Shigeru Sakurai; Kensuke Ozaki; Kenichi Yoshimura; Shinya Takahashi; Shin Yamamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-09-09

Review 6.  Endovascular strategies for post-dissection aortic aneurysm (PDAA).

Authors:  Zhaoxiang Zeng; Yuxi Zhao; Mingwei Wu; Xianhao Bao; Tao Li; Jiaxuan Feng; Rui Feng; Zaiping Jing
Journal:  J Cardiothorac Surg       Date:  2020-10-01       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.